603233.SHG Dashenlin Pharm Grp Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
20.47 CNY
Close of Nov 4, 2026
14.39 21.78
Market cap
CNY 24.2B
P/E
16.8x
P/B
3.25x
ROE
22.3%
Dividend yield
3.24%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 603233.SHG undervalued?

Graham number
Price20.47
Graham value13.15
Premium55.6%

603233.SHG trades 55.6% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Dashenlin Pharm Grp Co Ltd fundamental analysis

No fundamental analysis for Dashenlin Pharm Grp Co Ltd yet.

Dashenlin Pharm Grp Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Dashenlin Pharm Grp Co Ltd

DaShenLin Pharmaceutical Group Co., Ltd. engages in the manufacture, distribution, and retail of pharmaceutical products in China. It offers Chinese and Western patent medicines, ginseng and tonic herbs, Chinese herbal medicine slices, health products, medical devices, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.

Full company profile